
The company completed the phase-III and booster dose trials for its intranasal Covid-19 vaccine on August 22.
This vaccine candidate was evaluated in phase I, II and III clinical trials with successful results, a press release from…
Some people with COVID-19 have lingering symptoms for weeks or months after they begin to recover, a condition termed as…
The research, published recently in the New England Journal of Medicine, analysed the probability of vaccinated people becoming infected with…
Betaferon is a class of antiviral drug that is also naturally produced in the body and protect it from virus…
According to scientists, the lungs are more vulnerable to infection by the novel strains of coronavirus, including BA4 and BA5…
President Joe Biden’s administration expects to run out of federal funding for buying and distributing COVID-19 vaccines by January, although…
Even though intranasal vaccines can produce both local and systemic immunity, there can be challenges around long-lasting immunity, the company…
Currently, Sputnik V has been authorized in 71 countries with a total population of over 4 billion people and Sputnik…
The Food and Drug Administration on Monday ordered vaccine makers to tweak their shots to target BA.4 and BA.5 that…
The pilot project will be implemented in two districts of each state and Union Territories for three months, official sources…
The researchers from the University of Oxford, UK, noted that there is also an increased risk of anxiety and depression…
Sitharaman, who internationally launched the book ‘India’s Vaccine Growth Story – From Cowpox to Vaccine Maitry’ written by Sajjan Singh…
The Novavax team and a delegation from US was visiting SII’s campus in Pune to mark 75 years of US-India…
Launching the book ‘India’s Vaccine Growth Story’ by Sajjan Singh Yadav, Additional Secretary, Expenditure Department, Sitharaman said it is in…
On Tuesday, Sisodia met with senior Health Department officers and district magistrates on measures to step up the booster-dose coverage.
The precaution dose coverage among the 64,89,99,721 eligible population was eight per cent till July 14.
The district health department bulletin said in a bulletin that Gurgaon reported 357 cases on Monday, taking the active cases…